Rislenemdaz
目录号: A21907
NMDA receptor GluN2B 拮抗剂
Rislenemdaz(CERC-301)是一种口服生物利用度高且选择性的N-甲基-D-天冬氨酸(NMDA)受体亚单位2B(GluN2B)拮抗剂,其Ki和IC50分别为8.1纳摩尔和3.6纳摩尔。
Discription | Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC50 of 8.1 nM and 3.6 nM, respectively. |
---|
目录号 | A21907 |
---|---|
分子式 | C19H23FN4O2 |
分子量 | 358.41 |
CAS号 | 808732-98-1 |
SMILES | O=C(N1C[C@@H](F)[C@@H](CNC2=NC=CC=N2)CC1)OCC3=CC=C(C)C=C3 |
其他名称 | MK-0657, MK0657, MK 0657; CERC-301, CERC 301, CERC301 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2